New Regulations Include Price Erosion Mechanisms

A number of modifications to Estonia's laws on medicines and health insurance and the inauguration of a new regulatory body will alter the operations of the country's pharmaceutical and healthcare companies in 2010. Here BMI assesses some of the key changes and their potential impact on Estonia's business environment

To read the full article, please choose one of the following options: